Brief: Actuate Therapeutics Files Registration Statement For IPO
28/05/2024 12:08
May 28 (Reuters) - Actuate Therapeutics Inc ACTU.O :
* ACTUATE THERAPEUTICS FILES REGISTRATION STATEMENT FOR
INITIAL
PUBLIC OFFERING
Source text for Eikon: ID:nGNX2PYqWR
Further company coverage: ACTU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actuate Therapeutics
See all newsActuate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Actuate Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Health Rounds: Actuate Therapeutics drug improves survival odds in pancreatic cancer trial
Brief: Actuate Therapeutics Announces Plans To Expand Clinical Pipeline, Advancing Elraglusib Tablet Into A Phase 1/2 Clinical Program In Refractory Cancers
Brief: Actuate Therapeutics Inc - Reports Positive Phase 2 Trial Data For Elraglusib - SEC Filing